|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
146,000,000 |
Market
Cap: |
15.71(B) |
Last
Volume: |
1,713,779 |
Avg
Vol: |
1,333,523 |
52
Week Range: |
$92.79 - $212.65 |
|
Level
I Sector: |
Information Technology |
Level
II Sector: |
Electronics |
Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : 11.4 |
Insider 6 Months : 11.4 |
Insider 3/6 Months : 23.2 |
|
Guru Rank Number : 691 |
Guru Rank Value : 2.3 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co. provides whole-genome sequencing, genotyping, noninvasive prenatal testing (NIPT), and product support services. Using Co.'s services, customers can perform whole-genome sequencing projects and microarray projects (including large-scale genotyping studies and whole-genome association studies). Co. provides NIPT services through its partner laboratories that direct samples to Co. on a test send-out basis in its Clinical Laboratory Improvements Amendments-certified, College of Pathologists-accredited laboratory. Co. also provides support services to customers who have purchased its products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
7,330 |
7,330 |
7,330 |
7,330 |
Total Buy Value |
$991,672 |
$991,672 |
$991,672 |
$991,672 |
Total People Bought |
1 |
1 |
1 |
1 |
Total Buy Transactions |
1 |
1 |
1 |
1 |
Total Shares Sold |
0 |
0 |
1,815 |
22,740 |
Total Sell Value |
$0 |
$0 |
$314,105 |
$4,648,975 |
Total People Sold |
0 |
0 |
2 |
3 |
Total Sell Transactions |
0 |
0 |
4 |
17 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Reeves Kathryne Gambrell |
SVP, Chief Marketing Officer |
|
2020-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,187 |
1,187 |
|
- |
|
Goswami Joydeep |
SVP Corp Business Development |
|
2020-10-05 |
4 |
D |
$316.17 |
$36,360 |
D/D |
(115) |
2,877 |
|
- |
|
Dadswell Charles |
SVP & General Counsel |
|
2020-10-01 |
4 |
AS |
$312.82 |
$37,851 |
D/D |
(121) |
6,157 |
|
46% |
|
Desouza Francis A |
President and CEO |
|
2020-10-01 |
4 |
AS |
$306.99 |
$926,331 |
D/D |
(3,000) |
68,840 |
|
46% |
|
Flatley Jay T |
Director |
|
2020-09-15 |
4 |
AS |
$355.22 |
$1,420,880 |
D/D |
(4,000) |
210,933 |
|
23% |
|
Tousi Susan H |
SVP Product Development |
|
2020-09-09 |
4 |
AS |
$350.00 |
$70,000 |
D/D |
(200) |
45,268 |
|
17% |
|
Tousi Susan H |
SVP Product Development |
|
2020-09-08 |
4 |
AS |
$336.00 |
$33,600 |
D/D |
(100) |
45,468 |
|
18% |
|
Desouza Francis A |
President and CEO |
|
2020-09-01 |
4 |
AS |
$349.55 |
$1,056,964 |
D/D |
(3,000) |
71,840 |
|
4% |
|
Van Oene Mark |
SVP Chief Commercial Officer |
|
2020-09-01 |
4 |
AS |
$355.04 |
$221,953 |
D/D |
(625) |
17,648 |
|
4% |
|
Dadswell Charles |
SVP & General Counsel |
|
2020-09-01 |
4 |
AS |
$355.35 |
$599,475 |
D/D |
(1,687) |
6,278 |
|
4% |
|
Flatley Jay T |
Director |
|
2020-09-01 |
4 |
AS |
$355.35 |
$1,421,400 |
D/D |
(4,000) |
214,933 |
|
4% |
|
Ragusa Robert P |
SVP, Global Quality & Ops |
|
2020-08-31 |
4 |
AS |
$352.93 |
$1,775,907 |
D/D |
(5,000) |
8,103 |
|
1% |
|
Flatley Jay T |
Director |
|
2020-08-18 |
4 |
AS |
$354.03 |
$1,416,120 |
D/D |
(4,000) |
218,933 |
|
2% |
|
Mcginnis Karen K |
VP, Chief Accounting Officer |
|
2020-08-10 |
4 |
AS |
$357.01 |
$662,611 |
D/D |
(1,856) |
2,350 |
|
3% |
|
Tousi Susan H |
SVP Product Development |
|
2020-08-05 |
4 |
AS |
$397.40 |
$319,220 |
D/D |
(800) |
45,568 |
|
-12% |
|
Hoyt Aimee L |
SVP, Chief People Officer |
|
2020-08-04 |
4 |
AS |
$397.73 |
$11,534 |
D/D |
(29) |
3,498 |
|
-10% |
|
Flatley Jay T |
Director |
|
2020-08-04 |
4 |
AS |
$397.73 |
$1,590,920 |
D/D |
(4,000) |
222,933 |
|
-10% |
|
Dadswell Charles |
SVP & General Counsel |
|
2020-08-03 |
4 |
AS |
$385.19 |
$46,608 |
D/D |
(121) |
7,913 |
|
-13% |
|
Van Oene Mark |
SVP Chief Commercial Officer |
|
2020-08-03 |
4 |
AS |
$385.43 |
$240,894 |
D/D |
(625) |
18,255 |
|
-13% |
|
Desouza Francis A |
President and CEO |
|
2020-08-03 |
4 |
AS |
$385.59 |
$1,169,543 |
D/D |
(3,000) |
74,822 |
|
-13% |
|
Ronaghi Mostafa |
SVP, Entrepreneurial Devlopmt |
|
2020-07-27 |
4 |
D |
$393.04 |
$75,464 |
D/D |
(192) |
86,314 |
|
- |
|
Flatley Jay T |
Director |
|
2020-07-21 |
4 |
AS |
$399.00 |
$1,596,000 |
D/D |
(4,000) |
226,933 |
|
-14% |
|
Tousi Susan H |
SVP Product Development |
|
2020-07-20 |
4 |
AS |
$400.00 |
$200,000 |
D/D |
(500) |
46,354 |
|
-19% |
|
Flatley Jay T |
Director |
|
2020-07-07 |
4 |
AS |
$370.22 |
$1,480,880 |
D/D |
(4,000) |
230,933 |
|
-20% |
|
Aravanis Alexander |
SVP, Chief Technology Officer |
|
2020-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,295 |
3,295 |
|
- |
|
3466 Records found
|
|
Page 14 of 139 |
|
|